跳至主要内容
临床试验/NCT04793490
NCT04793490已完成不适用

Efficacy and Efficiency of Sphenopalatine Ganglion Block for Management of Post-dural Puncture Headache in Obstetric Patients-A Randomized Clinical Trial

Ain Shams University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2021年3月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Numeric rating pain score

研究概览

简要总结

The purpose of this trial is to study the efficacy and efficiency of sphenopalatine ganglion block for management of post dural puncture headache in obstetric patients

详细描述

Background and objectives: Post dural puncture headache(PDPH) is a common complication of lumbar puncture, it is likely due to the loss of cerebrospinal fluid into the epidural space through the dural tear. The prevalence of PDPH is higher in pregnant women.Sphenopalatine ganglion block (SPGB) is a non-invasive intervention with minimal adverse effects, it is indicated in acute and chronic facial/head pain like cluster headache, trigeminal neuralgia, post herpetic neuralgia and pain due to head and neck cancer.SPGB can be performed by different approaches:transnasal,transoral ,sub zygomatic and lateral infratemporal.Transnasal is the easiest, least invasive approach which can be done at bedside.

The objective of this trial is to study the efficacy and efficiency of sphenopalatine ganglion block for management of post-dural puncture headache in obstetric patients.The following will be recorded: pain score will be assessed using the numeric rating pain scale(NRS),heart rate and mean arterial pressure, onset and duration of analgesia, total dose of ketorolac, duration of hospital stay and patient satisfaction

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Female patients ASA I or II post caesarean section
  • Body weight between 60-100 kg
  • Active PDPH within days after spinal anesthesia not relieved with standard treatment such as, intravenous fluids, bed rest and caffeine.

排除标准

  • Patient refusal to participate in the study
  • Body mass index >35kg/m2
  • Patients with :coagulopathy ,nasal septal deviation,polyp
  • History of nasal bleeding
  • Allergy to local anesthetic

研究组 & 干预措施

Group A (Control group)

Other

Patients will receive paracetamol 1 g thrice daily intravenously

干预措施: paracetamol (Drug)

Group B (Sphenopalatine ganglion block group)

Active Comparator

patients will receive sphenopalatine ganglion block via transnasal approache by a cotton tipped applicator soaked in 2%lignocaine with 4 mg dexamethasone

干预措施: Sphenopalatine ganglion block (Procedure)

结局指标

主要结局

Numeric rating pain score

时间窗: First 24 hours after the procedure

Numeric rating pain score will be used to assess the efficacy of SPGB for treatment of PDPH

次要结局

  • Total analgesic consumption(First 24 hours after the procedure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marwa Mostafa Mohamed Ali Mowafi

Lecturer of anesthesia ,principal Investigator

Ain Shams University

研究点 (1)

Loading locations...

相似试验